Accès ouvert
2026
article
OpenAlex
Éric Therrien, Shulu Feng, Katherine Amberg-Johnson, Nadim Shaikh et autres
The clinical emergence of diverse c-MET mutations with resistance to approved inhibitors has created an urgent demand for next-generation inhibitors with efficacy against c-MET-resistant mutations while maintaining c-MET wild-type (WT) potency, selectivity over other kinases, and brain penetration. Here, we report a …
us
(code pays fourni par la source)
2026
article
OpenAlex
Steven K. Albanese, Brittany E. Hopkins, Andrea M. Olland, Alexis Fairman et autres
.
us, de
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Howook Hwang, Mee Y. Shelley, Andrew Placzek, Kevin R. DeMarco et autres
The development of a small-molecule suitable for clinical use involves optimization of ligand binding to an identified target protein but also frequently the reduction of binding to a variety of anti-target proteins known to pose translational risk. These anti-targets, often referred to …
us, gb
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Howook Hwang, Mee Y. Shelley, Andrew Placzek, Kevin R. DeMarco et autres
The development of a small-molecule suitable for clinical use involves optimization of ligand binding to an identified target protein but also frequently the reduction of binding to a variety of anti-target proteins known to pose translational risk. These anti-targets, often referred to …
us, gb
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Howook Hwang, Mee Y. Shelley, Andrew Placzek, Kevin R. DeMarco et autres
The development of a small-molecule suitable for clinical use involves optimization of ligand binding to an identified target protein but also frequently the reduction of binding to a variety of anti-target proteins known to pose translational risk. These anti-targets, often referred to …
us, gb
(code pays fourni par la source)
2025
article
OpenAlex
Anu Nagarajan, Katherine Amberg-Johnson, Evan Paull, Kunling Huang et autres
Drug resistance is a critical challenge in treating diseases like cancer and infectious disease. This study presents a novel computational workflow for predicting on-target resistance mutations to small molecule inhibitors (SMIs). The approach integrates genetic models with alchemical free energy perturbation (FEP+) …
us
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Anu Nagarajan, Katherine Amberg-Johnson, Evan Paull, Kunling Huang et autres
Drug resistance is a critical challenge in treating diseases like cancer and infectious disease. This study presents a novel computational workflow for predicting on-target resistance mutations to small molecule inhibitors (SMIs). The approach integrates genetic models with alchemical free energy perturbation (FEP+) …
us
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Wolfgang Damm, Steven Dajnowicz, Delaram Ghoreishi, Yalun Yu et autres
We report on the development and validation of the OPLS5 force field. OPLS5 further extends the accuracy of our previous model (OPLS4) with the addition of explicit polarization to improve model accuracy for molecular ions and cation-pi interactions. OPLS5 also includes advances …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Gregory A. Ross, Chao Tsang Lu, Guido Scarabelli, Steven K. Albanese et autres
Computational techniques can speed up the identification of hits and accelerate the development of candidate molecules for drug discovery. Among techniques for predicting relative binding affinities, the most consistently accurate is free energy perturbation (FEP), a class of rigorous physics-based methods. However, …
us
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Gregory A. Ross, Chao Tsang Lu, Guido Scarabelli, Steven K. Albanese et autres
It is now well recognized that computational techniques can greatly speed up the identification of hits and accelerate the optimization of such hits to lead series and development candidate molecules. In particular, a class of rigorous physics-based methods known as free energy …
us
(code pays fourni par la source)
Accès ouvert
2023
conference-abstract
OpenAlex
Joshua J. McElwee, Neelu Kaila, Samantha T. Carreiro, Sheetal Kumar et autres
Abstract The de novo pyrimidine biosynthetic pathway is an inducible cellular program which allows the rapid synthesis of pyrimidine nucleotides in proliferating cells, and the final rate-limiting step is catalyzed by cytidine triphosphate synthase (CTPS1 or CTPS2). A CTPS1 loss-of-function mutation in …
it, gb, us
(code pays fourni par la source)
Accès ouvert
2022
preprint
OpenAlex
Gregory A. Ross, Chao Tsang Lu, Guido Scarabelli, Steven K. Albanese et autres
us
(code pays fourni par la source)